Fig. 4From: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)Ordinal scale for severity. The vertical axes show the cumulative percentages of patients. LE last evaluation RRT renal replacement therapy, ECMO extracorporeal membrane oxygenationBack to article page